237 related articles for article (PubMed ID: 34267727)
1. Approaches to Gene Mutation Analysis Using Formalin-Fixed Paraffin-Embedded Adrenal Tumor Tissue From Patients With Primary Aldosteronism.
Nanba K; Rainey WE; Udager AM
Front Endocrinol (Lausanne); 2021; 12():683588. PubMed ID: 34267727
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.
Nishimoto K; Tomlins SA; Kuick R; Cani AK; Giordano TJ; Hovelson DH; Liu CJ; Sanjanwala AR; Edwards MA; Gomez-Sanchez CE; Nanba K; Rainey WE
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):E4591-9. PubMed ID: 26240369
[TBL] [Abstract][Full Text] [Related]
3. Molecular Heterogeneity in Aldosterone-Producing Adenomas.
Nanba K; Chen AX; Omata K; Vinco M; Giordano TJ; Else T; Hammer GD; Tomlins SA; Rainey WE
J Clin Endocrinol Metab; 2016 Mar; 101(3):999-1007. PubMed ID: 26765578
[TBL] [Abstract][Full Text] [Related]
4. Histopathology and Genetic Causes of Primary Aldosteronism in Young Adults.
Nanba K; Baker JE; Blinder AR; Bick NR; Liu CJ; Lim JS; Wachtel H; Cohen DL; Williams TA; Reincke M; Lyden ML; Bancos I; Young WF; Else T; Giordano TJ; Udager AM; Rainey WE
J Clin Endocrinol Metab; 2022 Aug; 107(9):2473-2482. PubMed ID: 35779252
[TBL] [Abstract][Full Text] [Related]
5. The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease.
Lim JS; Rainey WE
Horm Metab Res; 2020 Jun; 52(6):427-434. PubMed ID: 32227317
[TBL] [Abstract][Full Text] [Related]
6. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
Omata K; Satoh F; Morimoto R; Ito S; Yamazaki Y; Nakamura Y; Anand SK; Guo Z; Stowasser M; Sasano H; Tomlins SA; Rainey WE
Hypertension; 2018 Oct; 72(4):874-880. PubMed ID: 30354720
[TBL] [Abstract][Full Text] [Related]
7. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
Nanba K; Tsuiki M; Sawai K; Mukai K; Nishimoto K; Usui T; Tagami T; Okuno H; Yamamoto T; Shimatsu A; Katabami T; Okumura A; Kawa G; Tanabe A; Naruse M
J Clin Endocrinol Metab; 2013 Apr; 98(4):1567-74. PubMed ID: 23443813
[TBL] [Abstract][Full Text] [Related]
8. Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
Felizola SJ; Maekawa T; Nakamura Y; Satoh F; Ono Y; Kikuchi K; Aritomi S; Ikeda K; Yoshimura M; Tojo K; Sasano H
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():410-6. PubMed ID: 25151951
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
10. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
[TBL] [Abstract][Full Text] [Related]
11. Expression of aldosterone synthase and adrenocorticotropic hormone receptor in adrenal incidentalomas from normotensive and hypertensive patients: Distinguishing subclinical or atypical primary aldosteronism from adrenal incidentaloma.
Cao CX; Yang XC; Gao YX; Zhuang M; Wang KP; Sun LJ; Wang XS
Int J Mol Med; 2012 Dec; 30(6):1396-402. PubMed ID: 23023242
[TBL] [Abstract][Full Text] [Related]
12. Disordered CYP11B2 Expression in Primary Aldosteronism.
Gomez-Sanchez CE; Kuppusamy M; Reincke M; Williams TA
Horm Metab Res; 2017 Dec; 49(12):957-962. PubMed ID: 29202495
[TBL] [Abstract][Full Text] [Related]
13. Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.
Fallo F; Castellano I; Gomez-Sanchez CE; Rhayem Y; Pilon C; Vicennati V; Santini D; Maffeis V; Fassina A; Mulatero P; Beuschlein F; Reincke M
Endocrine; 2017 Dec; 58(3):503-512. PubMed ID: 28405879
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.
Gomez-Sanchez CE; Gomez-Sanchez EP; Nishimoto K
Horm Metab Res; 2020 Jun; 52(6):421-426. PubMed ID: 32289837
[TBL] [Abstract][Full Text] [Related]
15. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
Boulkroun S; Samson-Couterie B; Dzib JF; Lefebvre H; Louiset E; Amar L; Plouin PF; Lalli E; Jeunemaitre X; Benecke A; Meatchi T; Zennaro MC
Hypertension; 2010 Nov; 56(5):885-92. PubMed ID: 20937967
[TBL] [Abstract][Full Text] [Related]
16. Pathology and gene mutations of aldosterone-producing lesions.
Nishimoto K; Ogishima T; Sugiura Y; Suematsu M; Mukai K
Endocr J; 2023 Dec; 70(12):1113-1122. PubMed ID: 37766569
[TBL] [Abstract][Full Text] [Related]
17. Double somatic mutations in
Nanba K; Blinder AR; Udager AM; Hirokawa Y; Miura T; Okuno H; Moriyoshi K; Yamazaki Y; Sasano H; Yasoda A; Satoh-Asahara N; Rainey WE; Tagami T
Front Endocrinol (Lausanne); 2024; 15():1286297. PubMed ID: 38505749
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations in patients with primary aldosteronism.
Takeda Y
Hypertens Res; 2001 Sep; 24(5):469-74. PubMed ID: 11675938
[TBL] [Abstract][Full Text] [Related]
19. A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma.
Murakami M; Yoshimoto T; Minami I; Bouchi R; Tsuchiya K; Hashimoto K; Izumiyama H; Fujii Y; Endo T; Akashi T; Nishimoto K; Mukai K; Kihara K; Ogawa Y
Endocr Pathol; 2015 Dec; 26(4):328-33. PubMed ID: 26481629
[TBL] [Abstract][Full Text] [Related]
20. Somatic
Nanba K; Blinder AR; Rege J; Hattangady NG; Else T; Liu CJ; Tomlins SA; Vats P; Kumar-Sinha C; Giordano TJ; Rainey WE
Hypertension; 2020 Mar; 75(3):645-649. PubMed ID: 31983310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
